Correction: Exploring the Effects of Ixekizumab on Pain in Patients with Ankylosing Spondylitis Based on Objective Measures of Inflammation: Post Hoc Analysis from a Large Randomized Clinical Trial

• Kurt de Vlam,
• Walter P. Maksymowych,
• Gaia Gallo,
• Proton Rahman,
• Philip Mease,
• Venkatesh Krishnan,
• Conor J. McVeigh,
• Jeffrey Lisse,
• Danting Zhu,
• Rebecca J. Bolce,
• Philip G. Conaghan

Affiliations

Kurt de Vlam

University Hospital Leuven

Walter P. Maksymowych

Department of Medicine, Division of Rheumatology at the University of Alberta

Gaia Gallo

Eli Lilly and Company

Proton Rahman

Department of Medicine, Memorial University

Philip Mease

Swedish Medical Center/Providence St, Joseph Health and University of Washington

Venkatesh Krishnan

Eli Lilly and Company

Conor J. McVeigh

Eli Lilly and Company

Jeffrey Lisse

Eli Lilly and Company

Danting Zhu

Eli Lilly and Company

Rebecca J. Bolce

Eli Lilly and Company

Philip G. Conaghan

Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and NIHR Leeds Biomedical Research Centre